CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
Robotic-assisted mini-PCNLdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05835323
NCT05835323N/ACompleted
CompareCT.gov

Initial Experience of the Treatment of Kidney Stones With the MONARCH™ Platform, Urology

Auris Health, Inc.·interventional·Posted Apr 28, 2023·Updated Jul 8, 2025

In Brief

A clinical study evaluating Robotic-assisted mini-PCNL for Kidney Calculi. Completed, enrolled 15 participants across 1 site.

Detailed Summary

The purpose of this study is to collect descriptive performance data using the MONARCH Platform, Urology (a novel robotic device) to perform mini-percutaneous nephrolithotomy (kidney stone removal) procedures. Data gathered from this study will be used to optimize the robotic platform and inform training and education material for the future users.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKidney Calculi
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedApr 28, 2023
Enrollment StartJan 11, 2023
Primary CompletionSep 25, 2023
Study CompletionNov 1, 2023
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 3.2 years ago

Interventions

Robotic-assisted mini-PCNLdevice

Eligible participants will be enrolled to undergo robotic-assisted PCNL using the MONARCH Platform, Urology for the removal of kidney stones. The MONARCH Platform, Urology is a novel flexible robotic device that enables the clinician to obtain both transurethral and percutaneous access to a participant's kidney under continuous visualization for therapeutic application (for example, stone removal).